Skip to main content

Annals of Surgical Oncology

Ausgabe 3/2016

Inhalt (50 Artikel)

Editorial

Lobular Neoplasia: Another Reset in Management?

Julie Dunderdale, Seema Ahsan Khan

Healthcare Policy and Outcomes

Oncologists’ Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up

Heather B. Neuman, Nicole M. Steffens, Nora Jacobson, Amye Tevaarwerk, Bethany Anderson, Lee G. Wilke, Caprice C. Greenberg

Breast Oncology

Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome

Julian Johnson, Laura Esserman, Cheryl Ewing, Michael Alvarado, Catherine Park, Barbara Fowble

Breast Oncology

Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020)

Faina Nakhlis, Lauren Gilmore, Rebecca Gelman, Isabelle Bedrosian, Kandice Ludwig, E. Shelley Hwang, Shawna Willey, Clifford Hudis, J. Dirk Iglehart, Elizabeth Lawler, Nicole Y. Ryabin, Mehra Golshan, Stuart J. Schnitt, Tari A. King

Breast Oncology

Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor

Andrea L. Merrill, Suzanne B. Coopey, Rong Tang, Maureen P. McEvoy, Michele C. Specht, Kevin S. Hughes, Michelle A. Gadd, Barbara L. Smith

Breast Oncology

The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients’ Quality of Life Over 2-Year Follow-up

Donna B. Jeffe, Maria Pérez, Emily F. Cole, Ying Liu, Mario Schootman

Breast Oncology

Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?

Stacy Ugras, Cindy Matsen, Anne Eaton, Michelle Stempel, Monica Morrow, Hiram S. Cody III

Breast Oncology

Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy

Shannon K. Swisher, Jose Vila, Susan L. Tucker, Isabelle Bedrosian, Simona F. Shaitelman, Jennifer K. Litton, Benjamin D. Smith, Abigail S. Caudle, Henry M. Kuerer, Elizabeth A. Mittendorf

Breast Oncology

Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment

Stefan Stefanovic, Ingo Diel, Peter Sinn, Stefan Englert, Andre Hennigs, Christine Mayer, Sarah Schott, Markus Wallwiener, Maria Blumenstein, Michael Golatta, Joerg Heil, Joachim Rom, Christof Sohn, Andreas Schneeweiss, Florian Schuetz, Christoph Domschke

Breast Oncology

Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies

David Mattos, Lisa Gfrerer, Irving T. C. Ling, Richard G. Reish, Kevin S. Hughes, Elkan F. Halpern, Curtis Cetrulo, Amy S. Colwell, Jonathan M. Winograd, Michael J. Yaremchuk, William G. Austen Jr., Eric C. Liao

Breast Oncology

Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study

Ondrej Mestak, Veronika Hromadkova, Monika Fajfrova, Martin Molitor, Jan Mestak

Breast Oncology

Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?

Brandy L. Edwards, Christopher A. Guidry, Krista N. Larson, Wendy M. Novicoff, Jennifer A. Harvey, Anneke T. Schroen

Breast Oncology

Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?

B. Schaefgen, M. Mati, H. P. Sinn, M. Golatta, A. Stieber, G. Rauch, A. Hennigs, H. Richter, C. Domschke, F. Schuetz, C. Sohn, A. Schneeweiss, Joerg Heil

Breast Oncology

A Novel Light-Emitting Wire Enhances the Marking and Visualization of Pathologic Mammary Ducts During Selective Microdochectomy

Xiao-Peng Ma, Wei Wang, Yuan Kong, Yun Ren, Shao-Jun Liu, Jian Gao, De-Ling Wu, Fu-Sheng Den

Bone and Soft Tissue Sarcomas

Complications and Postoperative Mortality Rate After Surgery for Pathological Femur Fracture Related to Bone Metastasis: Analysis of a Nationwide Database

Yusuke Tsuda, Hideo Yasunaga, Hiromasa Horiguchi, Kiyohide Fushimi, Hirotaka Kawano, Sakae Tanaka

Bone and Soft Tissue Sarcomas

Prognosis of Primary and Recurrent Chondrosarcoma of the Rib

Eva Roos, Frits van Coevorden, Cornelis Verhoef, Michel W. Wouters, Herman M. Kroon, Pancras C. W. Hogendoorn, Winan J. van Houdt

Bone and Soft Tissue Sarcomas

Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma

Ann Y. Lee, Narasimhan P. Agaram, Li-Xuan Qin, Deborah Kuk, Christina Curtin, Murray F. Brennan, Samuel Singer

Colorectal Cancer

A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer

Yufeng Chen, Ruixue Yuan, Xianrui Wu, Xiaosheng He, Yang Zeng, Xinjuan Fan, Lei Wang, Jianping Wang, Ping Lan, Xiaojian Wu

Colorectal Cancer

Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis

Geert A. Simkens, Thijs R. van Oudheusden, Misha D. Luyer, Simon W. Nienhuijs, Grard A. Nieuwenhuijzen, Harm J. Rutten, Ignace H. de Hingh

Colorectal Cancer

Stenting as a Bridge to Surgery for Obstructive Colon Cancer: Does It Have Surgical Merit or Oncologic Demerit?

Sun Jin Park, Kil Yeon Lee, Se Hwan Kwon, Suk-Hwan Lee

Colorectal Cancer

Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis

Shih-Ching Chang, Pei-Ching Lin, Jen-Kou Lin, Chien-Hsing Lin, Shung-Haur Yang, Wen-Yi Liang, Wei-Shone Chen, Jeng-Kai Jiang

Colorectal Cancer

Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era

Ethan B. Ludmir, Ritu Arya, Yuan Wu, Manisha Palta, Christopher G. Willett, Brian G. Czito

Colorectal Cancer

Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study

Marianne Maillet, Olivier Glehen, Jerome Lambert, Diane Goere, Marc Pocard, Simon Msika, Guillaume Passot, Dominique Elias, Clarisse Eveno, Jean-Marc Sabaté, Nelson Lourenco, Thierry André, Jean-Marc Gornet

Colorectal Cancer

Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis

Christine Leowardi, Marie-Luise Schneider, Ulf Hinz, Jonathan M. Harnoss, Ignazio Tarantino, Felix Lasitschka, Alexis Ulrich, Markus W. Büchler, Martina Kadmon

Colorectal Cancer

Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database

Ciara R. Huntington, Danielle Boselli, James Symanowski, Joshua S. Hill, Anthony Crimaldi, Jonathan C. Salo

Colorectal Cancer

Distant Metastasis in Colorectal Cancer is a Risk Factor for Anastomotic Leakage

Samuel A. Käser, Diana Mattiello, Christoph A. Maurer

Colorectal Cancer

Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer

Soo Jung Lee, Byung Woog Kang, Yee Soo Chae, Hye Jin Kim, Su Yeon Park, Jun Seok Park, Gyu Seog Choi, Jong Gwang Kim

Colorectal Cancer

Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer

Mitsuru Ishizuka, Hitoshi Nagata, Kazutoshi Takagi, Yoshimi Iwasaki, Norisuke Shibuya, Keiichi Kubota

Colorectal Cancer

Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer

Akiko Hanyuda, Sun A. Kim, Alejandro Martinez-Fernandez, Zhi Rong Qian, Mai Yamauchi, Reiko Nishihara, Teppei Morikawa, Xiaoyun Liao, Kentaro Inamura, Kosuke Mima, Yin Cao, Xuehong Zhang, Kana Wu, Andrew T. Chan, Edward L. Giovannucci, Jeffrey A. Meyerhardt, Charles S. Fuchs, Ramesh A. Shivdasani, Shuji Ogino

Colorectal Cancer

A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)

Naohiro Yoshida, Tetsushi Kinugasa, Hiroaki Miyoshi, Kensaku Sato, Kotaro Yuge, Takafumi Ohchi, Shinya Fujino, Sachiko Shiraiwa, Mitsuhiro Katagiri, Yoshito Akagi, Koichi Ohshima

Thoracic Oncology

Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer

Hyung Soon Park, Minkyu Jung, Sang Joon Shin, Su Jin Heo, Chang Gon Kim, Min Goo Lee, Seung Hoon Beom, Chang Young Lee, Jin Gu Lee, Dae Joon Kim, Joong Bae Ahn

Gastrointestinal Oncology

CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma

Yusuke Sato, Satoru Motoyama, Hiroshi Nanjo, Akiyuki Wakita, Kei Yoshino, Tomohiko Sasaki, Yushi Nagaki, Jiajia Liu, Kazuhiro Imai, Hajime Saito, Yoshihiro Minamiya

Gastrointestinal Oncology

Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer

Daniele Marrelli, Karol Polom, Valeria Pascale, Carla Vindigni, Riccardo Piagnerelli, Lorenzo De Franco, Francesco Ferrara, Giandomenico Roviello, Lorenzo Garosi, Roberto Petrioli, Franco Roviello

Gastrointestinal Oncology

Laparoscopic Infrapyloric Area Lymph Node Dissection with No. 14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach

Qi-Yue Chen, Chang-Ming Huang, Jian-Xian Lin, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Xin-Tao Yang

Gynecologic Oncology

Single-Port Extra- and Transperitoneal Approach for Paraaortic Lymphadenectomy in Gynecologic Cancers: A Propensity-Adjusted Analysis

Clémentine Beytout, Enora Laas, Iptissem Naoura, Sofiane Bendifallah, Geoffroy Canlorbe, Marcos Ballester, Emile Daraï

Gynecologic Oncology

Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis

Koji Matsuo, Aida Moeini, Hiroko Machida, Christopher A. Scannell, Jennifer K. Casabar, Mamoru Kakuda, Sosuke Adachi, Jocelyn Garcia-Sayre, Yutaka Ueda, Lynda D. Roman

Gynecologic Oncology

Association Between Preoperative Chemotherapy and Postoperative Complications in Patients Undergoing Surgery for Ovarian Cancer

David W. Doo, Michael S. Guy, Kian Behbakht, Susan A. Davidson, Jeanelle Sheeder, Saketh R. Guntupalli

Gynecologic Oncology

Predictive Modeling: A New Paradigm for Managing Endometrial Cancer

Sofiane Bendifallah, Emile Daraï, Marcos Ballester

Gynecologic Oncology

Is It Time to Centralize Ovarian Cancer Care in the United States?

Renee A. Cowan, Roisin E. O’Cearbhaill, Ginger J. Gardner, Douglas A. Levine, Kara Long Roche, Yukio Sonoda, Oliver Zivanovic, William P. Tew, Evis Sala, Yulia Lakhman, Hebert A. Vargas Alvarez, Debra M. Sarasohn, Svetlana Mironov, Nadeem R. Abu-Rustum, Dennis S. Chi

Hepatobiliary Tumors

Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study

Chia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Teddy S. Nagaria, Rheun-Chuan Lee, Han-Chieh Lin, Teh-Ia Huo

Hepatobiliary Tumors

Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases

Giuseppe Zimmitti, Jose Soliz, Thomas A. Aloia, Vijaya Gottumukkala, Juan P. Cata, Ching-Wei D. Tzeng, Jean-Nicolas Vauthey

Melanomas

Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma

David Y. Lee, Kelly T. Huynh, Annabelle Teng, Briana J. Lau, Sarah Vitug, Ji-Hey Lee, Stacey L. Stern, Leland J. Foshag, Mark B. Faries

Melanomas

Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt Melanoma Trial

Michael E. Egger, Charles W. Kimbrough, Arnold J. Stromberg, Amy R. Quillo, Robert C. G. Martin II, Charles R. Scoggins, Kelly M. McMasters

Pancreatic Tumors

Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma

Daniel P. Nussbaum, Mohamed A. Adam, Linda M. Youngwirth, Asvin M. Ganapathi, Sanziana A. Roman, Douglas S. Tyler, Julie A. Sosa, Dan G. Blazer III

Pancreatic Tumors

Double Purse-String Telescoped Pancreaticogastro stomy using an Atraumatic Self-retaining Ring Retractor in a Subtotal Stomach-Preserving Pancreaticoduodenectomy

Masato Narita, Ryo Matsusue, Hiroaki Hata, Takashi Yamaguchi, Tetsushi Otani, Iwao Ikai

Pancreatic Tumors

Total Laparoscopic Central Pancreatectomy with Pancreaticogastrostomy for High-Risk Cystic Neoplasm

L. Schwarz, J. Fleming, M. Katz, J. Lee, T. Aloia, N. Vauthey, C. Conrad

Reconstructive Oncology

Optimization of Free-Flap Limb Salvage and Maximizing Function and Quality of Life Following Oncologic Resection: 12-Year Experience

Edward I. Chang, Alexander T. Nguyen, Jennifer K. Hughes, Julie Moeller, Hong Zhang, Melissa A. Crosby, Roman J. Skoracki, David W. Chang, Valerae O. Lewis, Matthew M. Hanasono

Urologic Oncology

High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma

Liu Yang, Yidong Liu, Huimin An, Yuan Chang, Weijuan Zhang, Yu Zhu, Le Xu, Jiejie Xu

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.